Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Candesartan vs Imidapril in ATR-AA Positive Hypertension
NCT00360763Phase 4Unknown
- Sponsor
- Huazhong University of Science and Technology
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of candesartan cilexetil in hypertension (HTN), sponsored by Huazhong University of Science and Technology. Status: unknown.
02
Drugs
candesartan cilexetil
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00360763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00360763.